Gatti, Milo; Pea, Federico, Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?, «INFECTIOUS DISEASE REPORTS», 2026, 18, Article number: 3, pp. 1 - 4 [articolo]Open Access
Gatti, Milo; Pea, Federico, Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations, «INFECTION AND DRUG RESISTANCE», 2026, Volume 19, pp. 1 - 23 [articolo]
Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion, «PHARMACEUTICS», 2026, 18, Article number: 91, pp. 1 - 20 [articolo]Open Access
Di Bella, Stefano; Geremia, Nicholas; Pea, Federico; Zeitlinger, Markus; Sanson, Gianfranco; Monticelli, Jacopo; Bergmann, Felix; Motet, Christian; Lambotte-Buffet, Christophe; Zerbato, Verena; Gatti, Milo, When and How to Use Subcutaneous Antibiotics, «CLINICAL INFECTIOUS DISEASES», 2026, 10.1093/cid/ciaf691, pp. 1 - 12 [articolo]
Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, pp. 1 - 12 [articolo]Open Access
Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F., A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1543 - 1551 [articolo]Open Access
Bonazzetti, Cecilia; Rocchi, Ettore; Toschi, Alice; Derus, Nicolas Riccardo; Sala, Claudia; Pascale, Renato; Rinaldi, Matteo; Campoli, Caterina; Pasquini, Zeno Adrien Igor; Tazza, Beatrice; Amicucci, Armando; Gatti, Milo; Ambretti, Simone; Viale, Pierluigi; Castellani, Gastone; Giannella, Maddalena, Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections, «NPJ DIGITAL MEDICINE», 2025, 8, Article number: 319, pp. 1 - 6 [articolo]Open Access
Rinaldi, M.; Gatti, M.; Giannella, M., Avoiding resistance development to newer drugs: open research lines, «CLINICAL MICROBIOLOGY AND INFECTION», 2025, s1, pp. 1 - 6 [articolo]
Donker, E. M.; Piët, J. D.; Brinkman, D. J.; Richir, M. C.; Papaioannidou, P.; Likic, R.; Sanz, E. J.; Christiaens, T.; Costa, J. N.; De Ponti, F.; Gatti, M.; Böttiger, Y.; Kramers, C.; Van Agtmael, M. A.; Tichelaar, J., Barriers and solutions for the European prescribing exam: a qualitative world café study, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2025, 81, pp. 1451 - 1459 [articolo]
Caselli, D.; Arico, M.; Castagnola, E.; Gatti, M., Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients, «ANTIBIOTICS», 2025, 14, Article number: 121, pp. 1 - 17 [articolo]
Gatti, Milo; Pea, Federico, Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2025, N/A, pp. 1 - 37 [articolo]
Cortegiani, Andrea; De Pascale, Gennaro; De Angelis, Giulia; Falcone, Marco; Ferrini, Arianna; Forniti, Arianna; Gatti, Milo; Girardis, Massimo; Grasselli, Giacomo; Pea, Federico; Rinaldi, Matteo; Sanguinetti, Maurizio; Viale, Pierluigi; Giarratano, Antonino, Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement, «JOURNAL OF ANESTHESIA, ANALGESIA AND CRITICAL CARE», 2025, 10.1186/s44158-025-00299-y, pp. 1 - 16 [articolo]
Rinaldi, Matteo; Rancan, Ilaria; Malerba, Federica; Gatti, Milo; Ancillotti, Leonardo; Tazza, Beatrice; Campoli, Caterina; Bonazzetti, Cecilia; Profiti, Beatrice; Caroccia, Natascia; Ambretti, Simone; Tumbarello, Mario; Viale, Pierluigi; Giannella, Maddalena, Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 2247 - 2256 [articolo]Open Access
Babich, Stella; Cojutti, Pier Giorgio; Gatti, Milo; Pea, Federico; Di Bella, Stefano; Monticelli, Jacopo, Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis, «JAC-ANTIMICROBIAL RESISTANCE», 2025, 7, Article number: dlaf066, pp. 1 - 4 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1153 - 1155 [articolo]Open Access
